Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
IntroductionChronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomised-controlled trial (GaPP2) to explore if there are measures wh...
Saved in:
Main Authors: | Lydia Coxon (Author), Maryam Amer (Author), Jane Daniels (Author), Ann M. Doust (Author), Scott C. Mackenzie (Author), Andrew W. Horne (Author), Katy Vincent (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative evaluation of the efficacy of gabapentin and gabapentin in combination with nortriptyline in the management of pain-related temporomandibular disorders
by: Mohsin Muzaffar Tak, et al.
Published: (2021) -
Effects of Topical Gabapentin on Ocular Pain and Tear Secretion
by: Maurizio Cammalleri, et al.
Published: (2021) -
Systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosisAJOG Global Reports at a Glance
by: Greg Marchand, MD, FACS, FICS, FACOG, et al.
Published: (2022) -
Pelvic pain correlates with peritoneal macrophage abundance not endometriosis
by: Douglas A Gibson, et al.
Published: (2021) -
Gabapentin improves neuropathic pain in Minamata disease model rats
by: Masatake Fujimura
Published: (2024)